Sequencing DNA is cheap, analysis not so much

Chemical & Engineering News recently noted in a cover story that the increase in genomics research presents some opportunities for informatics firms. For one thing, analyzing genomic data often requires expertise from multiple fields such as molecular biology, computational biology, genetics, and pathology. While the cost of sequencing a human genome is speeding toward $1,000, the costs to make the resulting data clinically relevant appear to be much higher. Software firms like Accelrys and Ingenuity Systems are working to take advantage of the needs of the drug industry to analyze genomic information. Story

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.